# Continuing or Discontinuing ACE/ARBs in Patients With Chronic Kidney Disease Undergoing Coronary Angiography

> **NCT05271448** · NA · UNKNOWN · sponsor: **An-Najah National University** · enrollment: 600 (estimated)

## Conditions studied

- Contrast-induced Nephropathy
- Chronic Kidney Diseases
- Ischemic Heart Disease

## Interventions

- **OTHER:** Continue ACEI or ARBs ( Enalapril , Ramipril , Valsartan , Candesartan, Losartan )
- **OTHER:** Hold ACEI or ARBs

## Key facts

- **NCT ID:** NCT05271448
- **Lead sponsor:** An-Najah National University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06-01
- **Primary completion:** 2024-06-01
- **Final completion:** 2024-08-01
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2023-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05271448

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05271448, "Continuing or Discontinuing ACE/ARBs in Patients With Chronic Kidney Disease Undergoing Coronary Angiography". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05271448. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*